Paulo Bruno Araujo Loureiro

Mr. Paulo Bruno Araujo Loureiro

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2024 in BioTech
Verified
Journal Article
Open access
PDF file
GAGleycyelly Rodrigues Araujo
Gleycyelly Rodrigues Araujo
PCPalloma Christine Queiroga Gomes da Costa
Palloma Christine Queiroga Gomes da Costa
PNPaula Lima Nogueira
Paula Lima Nogueira
DADanielle da Nóbrega Alves
Danielle da Nóbrega Alves
AFAlana Rodrigues Ferreira
Alana Rodrigues Ferreira
LUCIANA SCOTTILUCIANA SCOTTI
LUCIANA SCOTTI
Candida species are frequently implicated in the development of both superficial and invasive fungal infections, which can impact vital organs. In the quest for novel strategies to combat fungal infections, there has been growing interest in exploring synthetic and semi-synthetic products, particularly chromone derivatives, renowned for their antimicrobial properties. In the analysis of the antifungal activity of the compound (E)-benzylidene-chroman-4-one against Candida, in silico and laboratory tests were performed to predict possible mechanisms of action pathways, and in vitro tests were performed to determine antifungal activity (MIC and MFC), to verify potential modes of action on the fungal cell membrane and wall, and to assess cytotoxicity in human keratinocytes. The tested compound exhibited predicted affinity for all fungal targets, with the highest predicted affinity observed for thymidylate synthase (−102.589 kJ/mol). MIC and CFM values ranged from 264.52 μM (62.5 μg/mL) to 4232.44 μM (1000 μg/mL). The antifungal effect likely occurs due to the action of the compound on the plasma membrane. Therefore, (E)-benzylidene-chroman-4-one showed fungicidal-like activity against Candida spp., possibly targeting the plasma membrane.

16 November 2024 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
CACamyla Caroliny Neves de Andrade
Camyla Caroliny Neves de Andrade
ALAna Luiza de Oliveira Lopes
Ana Luiza de Oliveira Lopes
SDSâmia Sousa Duarte
Sâmia Sousa Duarte
FAFátima de Lourdes Assunção Araújo de Azevedo
Fátima de Lourdes Assunção Araújo de Azevedo
PLPaulo Bruno Araujo Loureiro
Paulo Bruno Araujo Loureiro
MBMarianna Castello Branco
Marianna Castello Branco

7 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
EAEdileuza Assis
Edileuza Assis
RARodrigo Andrade
Rodrigo Andrade
JSJoanda P. R. e Silva
Joanda P. R. e Silva
LMLucas H. Martorano
Lucas H. Martorano
GAGeraldo Moisés Wanderley Amorim
Geraldo Moisés Wanderley Amorim
MSMarcelo Silva
Marcelo Silva
Seven new abietane diterpenoids, comprising medusanthol A–G (1–3, 5, 7–9) and two previously identified analogs (4 and 6), were isolated from the hexane extract of the aerial parts of Medusantha martiusii. The structures of the compounds were elucidated by HRESIMS, 1D/2D NMR spectroscopic data, IR spectroscopy, NMR calculations with DP4+ probability analysis, and ECD calculations. The anti-neuroinflammatory potential of compounds 1–7 was evaluated by determining their ability to inhibit the production of nitric oxide (NO) and the proinflammatory cytokine TNF-α in BV2 microglia stimulated with LPS and IFN-γ. Compounds 1–4 and 7 exhibited decreased NO levels at a concentration of 12.5 µM. Compound 1 demonstrated strong activity with an IC50 of 3.12 µM, and compound 2 had an IC50 of 15.53 µM; both compounds effectively reduced NO levels compared to the positive control quercetin (IC50 11.8 µM). Additionally, both compounds significantly decreased TNF-α levels, indicating their potential as promising anti-neuroinflammatory agents.